Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

The Effects of Immunomodulation with Corticosteroids to Manage an AAV Capsid Immune response in the Phase I/II Study of SPK-8011

Matthew S. Evans, Witold B. Rybka, Stacy E. Croteau, Huyen Tran, John E.J. Rasko, Kristen Jaworski, Amy MacDougall, Savina Jaeger, Federico Mingozzi, Tiffany Chang, Gallia Levy

Blood (2022) 140 (Supplement 1): 10654–10655.

https://doi.org/10.1182/blood-2022-159017

Published: 2022

Journal Articles

Cdx Report Program: Heterogeneity Revealed in Current Reporting Practices for Hemato-Oncology Companion Diagnostic (CDx) Markers in Multiple Countries

Sabit Delic, PhD, Piers Blombery, MBBS, María José Calasanz, PhD, Devon S. Chabot-Richards, MD, Dolors Colomer, PhD, Matteo G Della Porta, MD, Paul A S Evans, PhD, Torsten Haferlach, MD, Joanne Mason, FRCPath, Jay L Patel, MD, William S. Stevenson, MBBS, PhD, Christian Thiede, MD, Maria Teresa Voso, MD, Jordan Clark

Blood (2019) 134 (Supplement_1): 5837.

https://doi.org/10.1182/blood-2019-128652

Published: 2019

Journal Articles

Targeted Sequencing Predicts the Development of Myeloid Malignancies and Clinical Outcome in Patients with Unexplained Cytopenia

Catherine Cargo, MB, FRCPath, Kelly Bolton, MD PhD, Tumas Beinortas, MBBS, Paul Glover, MSc, Michael Short, Alexandra Smith, PhD, Jan Taylor, PhD MSc, BSc, Paul A S Evans, PhD, Elli Papaemmanuil, PhD, Simon Crouch, PhD BA, MA, MSc

Blood (2019) 134 (Supplement_1): 1712.

https://doi.org/10.1182/blood-2019-131402

Published: 2019

Journal Articles

Therapeutic Candidate Alpn-101, a Dual ICOS/CD28 Antagonist, Potently Suppresses Human/NSG Mouse Xenograft Graft Vs. Host Disease (GvHD) in a Dose Ranging Study and Reduces Disease Activity in a Mouse Model of Hemophagocytic Lymphohistiocytosis (HLH)

Stacey R. Dillon, PhD, Katherine E. Lewis, PhD, Katherine Verbist, PhD, Paige Tedrick, PhD, Sabrin Albeituni, PhD, Ryan Swanson, B.S., Lawrence S. Evans, B.S., Steven D Levin, PhD, Mark W. Rixon, PhD, Stanford L. Peng, MD, PhD, Kim E. Nichols, MD, Kristine M. Swiderek, PhD

Blood (2018) 132 (Supplement 1): 2037.

https://doi.org/10.1182/blood-2018-99-110001

Published: 2018

Journal Articles

Novel Variant Ig Domain (vIgD) Proteins Generated Via Directed Evolution of Igsf Domains Have Therapeutic Efficacy in Animal Models of Graft Versus Host Disease

Steven D Levin, PhD, Lawrence S. Evans, Erika Rickel, Martin F. Wolfson, Stacey R. Dillon, PhD, Michael G. Kornacker, PhD, Ryan Swanson, Stanford L. Peng, MDPhD

Blood (2017) 130 (Supplement 1): 1892.

https://doi.org/10.1182/blood.V130.Suppl_1.1892.1892

Published: 2017

Journal Articles

Minimal residual disease is an independent predictor for 10-year survival in CLL

Marwan Kwok, Andy C. Rawstron, Abraham Varghese, Paul A. S. Evans, Sheila J. M. O’Connor, Chi Doughty, Darren J. Newton, Paul Moreton, Peter Hillmen

Blood (2016) 128 (24): 2770–2773.

https://doi.org/10.1182/blood-2016-05-714162

Published: 2016

Includes: Supplemental data

Journal Articles

Clinical Results in Heavily Pre-Treated, Drug Refractory Hematologic Malignancies Using Chemotherapy and Targeted Agents Selected By Ex Vivo Analysis of Programmed Cell Death (EVA/PCD)

Vinicius Renan Pinto Mattos, MD, Nelson Hamerschlak, MD PhD, Isabel Nagle Reis, MD, Dirceu Hamilton Cordeiro Campelo, MD, Michelle Petrolli Silveira, MD, Flavia Munhoz Ferreira, MD, Juliano Cordova Vargas, MD, Paulo Vidal Campregher, MD, Fabio P.S. Santos, MD, Fabio R. Kerbauy, MD PhD, Joao C. C. Guerra, MD PhD, Claudio Galvão Castro Júnior, MD, Steven S. Evans, MS, Robert Nagourney, MD

Blood (2015) 126 (23): 3249.

https://doi.org/10.1182/blood.V126.23.3249.3249

Published: 2015

Journal Articles

Development of a Novel Automated Screening Method for Detection of FVIII Inhibitors

Matthew S. Evans, MD, M. Elaine Eyster, MD, Keri J. Donaldson, MD, Michael H. Creer, MD

Blood (2014) 124 (21): 5040.

https://doi.org/10.1182/blood.V124.21.5040.5040

Published: 2014

Journal Articles

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

Andy C. Rawstron, Michael J. Green, Anita Kuzmicki, Ben Kennedy, James A. L. Fenton, Paul A. S. Evans, Sheila J. M. O'Connor, Stephen J. Richards, Gareth J. Morgan, Andrew S. Jack, Peter Hillmen

Blood (2002) 100 (2): 635–639.

https://doi.org/10.1182/blood.V100.2.635

Published: 2002

Journal Articles

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Andy C. Rawstron, Ben Kennedy, Paul A. S. Evans, Faith E. Davies, Stephen J. Richards, Andy P. Haynes, Nigel H. Russell, Geoff Hale, Gareth J. Morgan, Andrew S. Jack, Peter Hillmen

Blood (2001) 98 (1): 29–35.

https://doi.org/10.1182/blood.V98.1.29

Published: 2001

Journal Articles

Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules

Sharon S. Evans, Wan-Chao Wang, Mark D. Bain, Randy Burd, Julie R. Ostberg, Elizabeth A. Repasky

Blood (2001) 97 (9): 2727–2733.

https://doi.org/10.1182/blood.V97.9.2727

Published: 2001

Journal Articles

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

K. Tobal, J. Newton, M. Macheta, J. Chang, G. Morgenstern, P. A. S. Evans, G. Morgan, G. S. Lucas, J. A. Liu Yin

Blood (2000) 95 (3): 815–819.

https://doi.org/10.1182/blood.V95.3.815.003k30_815_819

Published: 2000

Journal Articles

Prospective evaluation of the clinical usefulness of an antigen- specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias

TA Brighton, S Evans, PA Castaldi, CN Chesterman, BH Chong

Blood (1996) 88 (1): 194–201.

https://doi.org/10.1182/blood.V88.1.194.194

Published: 1996

Journal Articles

Chronic Hemolytic Anemia Due to Cold Agglutinins: A 20-Year History of Benign Gammopathy With Response to Chlorambucil

Robert S. Evans, M.D., Elizabeth Baxter, B.S., Bruce C. Gilliland, M.D.

Blood (1973) 42 (3): 463–470.

https://doi.org/10.1182/blood.V42.3.463.463

Published: 1973

Journal Articles

Studies on the Dynamics of the Reaction Between Rh Antibody and Antigen

ROBERT S. EVANS, WINSTON K. MEBUST, MARY T. HICKEY

Blood (1960) 16 (4): 1469–1478.

https://doi.org/10.1182/blood.V16.4.1469.1469

Published: 1960

Journal Articles

Panels in Therapy. X. Treatment of Acute ITP

C. LOCKARD CONLEY, ROBERT S. EVANS, WILLIAM J. HARRINGTON, STEVEN O. SCHWARTZ

Blood (1956) 11 (4): 384–390.

https://doi.org/10.1182/blood.V11.4.384.384

Published: 1956

Journal Articles

ACQUIRED HEMOLYTIC ANEMIA : I. THE RELATION OF ERYTHROCYTE ANTIBODY PRODUCTION TO ACTIVITY OF THE DISEASE. II. THE SIGNIFICANCE OF THROMBOCYTOPENIA AND LEUKOPENIA

ROBERT S. EVANS, M.D., ROSE T. DUANE, A.B.

Blood (1949) 4 (11): 1196–1213.

https://doi.org/10.1182/blood.V4.11.1196.1196

Published: 1949

Journal Articles

EOSINOPHILIC LEUKEMIA : REPORT OF A CASE WITH AUTOPSY CONFIRMATION; REVIEW OF THE LITERATURE

THEODORE S. EVANS, M.D., ROBERT R. NESBIT, M.D.

Blood (1949) 4 (5): 603–613.

https://doi.org/10.1182/blood.V4.5.603.603

Published: 1949

Journal Articles

OBSERVATIONS ON THE EFFECT OF IRRADIATION IN CHRONIC ACQUIRED HEMOLYTIC ANEMIA EXHIBITING HEMOLYTIC ACTIVITY FOR TRANSFUSED ERYTHROCYTES

ROBERT S. EVANS, M.D., ROSE T. DUANE, A.B.

Blood (1947) 2 (1): 72–84.

https://doi.org/10.1182/blood.V2.1.72.72

Published: 1947

NARROW

The Effects of Immunomodulation with Corticosteroids to Manage an AAV Capsid Immune response in the Phase I/II Study of SPK-8011

Cdx Report Program: Heterogeneity Revealed in Current Reporting Practices for Hemato-Oncology Companion Diagnostic (CDx) Markers in Multiple Countries

Targeted Sequencing Predicts the Development of Myeloid Malignancies and Clinical Outcome in Patients with Unexplained Cytopenia

Therapeutic Candidate Alpn-101, a Dual ICOS/CD28 Antagonist, Potently Suppresses Human/NSG Mouse Xenograft Graft Vs. Host Disease (GvHD) in a Dose Ranging Study and Reduces Disease Activity in a Mouse Model of Hemophagocytic Lymphohistiocytosis (HLH)

Novel Variant Ig Domain (vIgD) Proteins Generated Via Directed Evolution of Igsf Domains Have Therapeutic Efficacy in Animal Models of Graft Versus Host Disease

Minimal residual disease is an independent predictor for 10-year survival in CLL

Clinical Results in Heavily Pre-Treated, Drug Refractory Hematologic Malignancies Using Chemotherapy and Targeted Agents Selected By Ex Vivo Analysis of Programmed Cell Death (EVA/PCD)

Development of a Novel Automated Screening Method for Detection of FVIII Inhibitors

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules

Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse

Prospective evaluation of the clinical usefulness of an antigen- specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias

Chronic Hemolytic Anemia Due to Cold Agglutinins: A 20-Year History of Benign Gammopathy With Response to Chlorambucil

Studies on the Dynamics of the Reaction Between Rh Antibody and Antigen

Panels in Therapy. X. Treatment of Acute ITP

ACQUIRED HEMOLYTIC ANEMIA : I. THE RELATION OF ERYTHROCYTE ANTIBODY PRODUCTION TO ACTIVITY OF THE DISEASE. II. THE SIGNIFICANCE OF THROMBOCYTOPENIA AND LEUKOPENIA

EOSINOPHILIC LEUKEMIA : REPORT OF A CASE WITH AUTOPSY CONFIRMATION; REVIEW OF THE LITERATURE

OBSERVATIONS ON THE EFFECT OF IRRADIATION IN CHRONIC ACQUIRED HEMOLYTIC ANEMIA EXHIBITING HEMOLYTIC ACTIVITY FOR TRANSFUSED ERYTHROCYTES

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only